Alphabet (GOOGL) is expected to release its fourth-quarter earnings results after the closing bell on Tuesday.
Isomorphic Labs launches into an already well-populated drug discovery category, with many large drugmakers exploring the technology along with a host of specialist players like Exscientia ...
We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...
Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.
在2024年世界经济论坛上,诺贝尔化学奖得主、DeepMind创始人德米斯·哈萨比斯(Demis ...
在达沃斯世界经济论坛上,Google DeepMind的CEO Demis Hassabis震撼发布了一个引人注目的预测:首批由人工智能辅助设计的药物或将在2025年前进行临床试验!作为Isomorphic Labs的负责人,Hassabis表示,"我们预计到年底会有一些AI设计的药物进入临床试验,这是我们的目标。"自2021年以来,Isomorphic ...